Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NL-OMON42693
NL-OMON42693CompletedNot Applicable

The Efficacy of Pro- and Anticoagulant Therapy in Plasma of Patients with Cirrhosis undergoing Orthotopic Liver Transplantation - EPAC-OLT

niversitair Medisch Centrum Groningen0 sites60 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
60
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • •Orthotopic Liver Transplantation for cirrhosis at the UMCG
  • •Age >18 years
  • •Signed informed consent

Exclusion Criteria

  • •Acute liver failure
  • •Documented history of hereditary thrombophilia
  • •Use of vitamin K antagonists
  • •Transfusion of blood products (<7 days)
  • •Deep venous thrombosis (<30 days)

Investigators

Similar Trials

Completed
Not Applicable
The efficacy of pro- and anticoagulant therapy in plasma from patients with liver cirrhosis .coagulation.hemostasis10064477
NL-OMON37417niversitair Medisch Centrum Groningen126
Completed
Not Applicable
Efficacy and safety of anticoagulant treatment using new alternative antithrombotic agents in acute cardioembolic stroke with nonvalvular atrial fibrillation.cerebral infarction
JPRN-UMIN000010477Department of Neurology, Kansai Medical University50
Recruiting
Not Applicable
Efficacy and safety of anticoagulant treatment using New oral anticoagulant (edoxaban) in atrial fibrillation after cardiac surgery.arterial fibrillation after cardiac surgery (nonvalvular disease)
JPRN-UMIN000021138ihon University school of medicine150
Not yet recruiting
Phase 3
Effectiveness and safety of blood thinning agent (Anticoagulation) in patients with dying limb with poor blood supply (Digital Gangrene) and an underlying immune system related disease (Connective Tissue Disease)
CTRI/2024/03/063481Department of Clinical Immunology & Rheumatology
Not yet recruiting
Not Applicable
The efficacy and safety of anticoagulant therapy Arixtra Injection for the prevention of the vein thromboembolism in laparoscopic colorectal surgerycolorectal cancer
JPRN-UMIN000007005Osaka Medical College200
The Efficacy of Pro- and Anticoagulant... | Clinical Trial